AU2003229627A1 - Ve-ptp as regulator of ve-cadherin mediated processes or disorders - Google Patents
Ve-ptp as regulator of ve-cadherin mediated processes or disordersInfo
- Publication number
- AU2003229627A1 AU2003229627A1 AU2003229627A AU2003229627A AU2003229627A1 AU 2003229627 A1 AU2003229627 A1 AU 2003229627A1 AU 2003229627 A AU2003229627 A AU 2003229627A AU 2003229627 A AU2003229627 A AU 2003229627A AU 2003229627 A1 AU2003229627 A1 AU 2003229627A1
- Authority
- AU
- Australia
- Prior art keywords
- ptp
- disorders
- regulator
- mediated processes
- cadherin mediated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
- C12Y301/03048—Protein-tyrosine-phosphatase (3.1.3.48)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Cell Biology (AREA)
- Pain & Pain Management (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02007837.4 | 2002-04-08 | ||
EP02007837 | 2002-04-08 | ||
PCT/EP2003/003645 WO2003084565A2 (en) | 2002-04-08 | 2003-04-08 | Ve-ptp as regulator of ve-cadherin mediated processes or disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003229627A1 true AU2003229627A1 (en) | 2003-10-20 |
Family
ID=28685843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003229627A Abandoned AU2003229627A1 (en) | 2002-04-08 | 2003-04-08 | Ve-ptp as regulator of ve-cadherin mediated processes or disorders |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003229627A1 (en) |
WO (1) | WO2003084565A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006055416A2 (en) * | 2004-11-15 | 2006-05-26 | Eyetech Pharmaceuticals, Inc. | Transgenic mouse capable of over-expressing vascular endothelial protein tyrosine phosphatase (ve-ptp) |
MY150400A (en) | 2006-04-07 | 2014-01-15 | Aerpio Therapeutics Inc | Antibodies that bind human protein tyrosine phosphatase beta (hptpbeta) and uses thereof |
US7622593B2 (en) | 2006-06-27 | 2009-11-24 | The Procter & Gamble Company | Human protein tyrosine phosphatase inhibitors and methods of use |
MY160399A (en) | 2009-07-06 | 2017-03-15 | Aerpio Therapeutics Inc | Compounds, compositions, and methods for preventing metastasis of cancer cells |
CA2850830A1 (en) | 2011-10-13 | 2013-04-18 | Aerpio Therapeutics, Inc. | Methods for treating vascular leak syndrome and cancer |
US20150050277A1 (en) | 2013-03-15 | 2015-02-19 | Aerpio Therapeutics Inc. | Compositions and methods for treating ocular diseases |
JP6483148B2 (en) | 2014-03-14 | 2019-03-13 | エアーピオ セラピューティクス インコーポレイテッド | HPTP-β inhibitor |
WO2016115092A1 (en) * | 2015-01-12 | 2016-07-21 | La Jolla Institute For Allergy And Immunology | Methods for targeting host vascular mechanism for therapeutic protection against hemorrhagic fever |
CN113713101B (en) | 2015-09-23 | 2023-07-28 | 视点制药公司 | Methods of treating intraocular pressure with TIE-2 activators |
JP7564824B2 (en) | 2019-04-29 | 2024-10-09 | アイポイント ファーマシューティカルズ, インコーポレイテッド | Tie-2 activator targeting Schlemm's canal |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9604731D0 (en) * | 1996-12-20 | 1996-12-20 | Tamas Bartfai Konsulting Ab | A component of intercellular junctions in the endothelium |
EP1046715A1 (en) * | 1999-04-23 | 2000-10-25 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Interaction of vascular-endothelial protein-tyrosine phosphatase with the angiopoietin receptor tie-2 |
-
2003
- 2003-04-08 AU AU2003229627A patent/AU2003229627A1/en not_active Abandoned
- 2003-04-08 WO PCT/EP2003/003645 patent/WO2003084565A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003084565A3 (en) | 2004-03-25 |
WO2003084565A2 (en) | 2003-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003274342A1 (en) | Compositions for the treatment of autoimmune disorders | |
AU2003286567A1 (en) | Methods for the treatment of skin disorders | |
AU2003261405A1 (en) | Regulation of transcription elongation factors | |
AU2003249983A1 (en) | Piperidines useful for the treatment of central nervous system disorders | |
AU2003236991A1 (en) | Representations of processes | |
AU2003228819A1 (en) | Combinations for the treatment of inflammatory skin disorders | |
AU2002334321A1 (en) | Method for the production of phytoalexins | |
AU2003206803A1 (en) | Production of alkenones | |
AU2003293099A1 (en) | Treatment of dna damage related disorders | |
AU2003229627A1 (en) | Ve-ptp as regulator of ve-cadherin mediated processes or disorders | |
AU2003233358A1 (en) | Method of viewing and controlling balance of the vertebral column | |
AU2003293895A1 (en) | Method for the production of isocyanates | |
AU2002952155A0 (en) | Production of titania | |
AU2003248990A1 (en) | Method of controlling scale formation | |
AU2003275505A1 (en) | Electowinning of metals | |
AU2003206367A1 (en) | Technical field of the invention | |
AU2003292784A1 (en) | Method of refining metal surface and metal product by the method | |
AU2003238443A1 (en) | Separation of molecules | |
AU2003250329A1 (en) | Regulation of novel human asparagine-hydroxylases | |
AU2003259689A1 (en) | 3-imino-2-indolones for the treatment of depression and/or anxiety | |
AU2002361488A1 (en) | Field and background of the invention | |
AU2003278748A1 (en) | Chemotherapy method using-rays background of the invention | |
AU2003266271A1 (en) | Regulation of human esterase | |
AU2003245879A1 (en) | Method for the production of substituted trifluoroetylenes | |
AU2003238034A1 (en) | Novel use of imidazotriazinones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |